arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

CVS HEALTH Corp

CVS
$85.86 ▼ -1.22 (-1.40%) at close
Healthcare ·Retail-Drug Stores and Proprietary Stores ·USRetail-Drug Stores and Proprietary Stores
75 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Bullish
auto_awesome

Analytical Summary

CVS HEALTH Corp shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $109.8B
Dividend Yield 0.77%
Revenue Growth 7.3%
Op. Margin 4.4%
ROIC 4.4%
FCF / Share $4.42
Trailing P/E 36.9x
Price / Book 1.4x
FCF Yield 5.2%
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

75-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$106.10B
↑ +7.3%
Net Income Profit after all expenses
$2.98B
↑ +191.8%
Operating Margin Operating profit as % of sales
4.4%
↓ -4.9% 31th
FCF / Share Free cash flow per share
$4.42
↑ +65.5%
Long-Term Debt Long-term obligations
$63.48B
↓ -3.4%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
32
Returns
48
Financial Health
77
Cash Quality
95

Dividend History

Dividend / share · sourced from SEC filings
$2.66 Latest / share
+0.0% YoY
+8.4% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 20 years · 75 quarters